NUTRIBAND INCNTRB
ASignal's systematic analysis rates NTRB as Bearish.
Reflects the latest available analysis · analyzed Oct 10, 2026
The case on NTRB
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Debt-to-equity ratio of 0.04x indicates strong financial health
- Current ratio of 4.21x suggests solid short-term liquidity
- Quick ratio of 3.80x supports near-term solvency strength
- MACD histogram shows potential trend stabilization
- Negative RSI at 42.83 nearing oversold territory
- MACD below signal line indicating bearish momentum
- Negative price momentum of -0.192
- Operating margin of -203.57% reflects severe profitability issues
- Negative return on equity (-100.75%) and return on assets (-53.48%)
- Negative operating and free cash flow
See the full verdict on NTRB
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes NTRB
Most investors never get a second opinion, let alone several. ASignal runs NTRB past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.